Leave 'em alone - Why continuous variables should be analyzed as such

Neuroepidemiology

Volumn 30, Issue 3, 2008, Pages 138-139

  Van Walraven, Carl ^a,c   Hart, Robert G ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; CALCULATION; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MEDICAL RESEARCH; NEOPLASM; OUTCOME ASSESSMENT; RISK ASSESSMENT; SIMULATION; STATISTICAL ANALYSIS; STROKE;

CONFOUNDING FACTORS (EPIDEMIOLOGY); EFFECT MODIFIERS (EPIDEMIOLOGY); FACTOR ANALYSIS, STATISTICAL; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 43449088235     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126908     Document Type: Editorial

References (11)

1. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA, et al: Issues in the reporting of epidemiological studies: a survey of recent practice. Br Med J 2004;329:883.
2. Royston P, Altman DG, Sauerbrei W: Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006;25:127-141.
3. Zhao LP, Kolonel LN: Efficiency loss from categorizing quantitative exposures into qualitative exposures in case-control studies. Am J Epidemiol 1992;136:464-474.
4. Selvin S: Statistical Power and Sample Size Calculations: Statistical Analysis of Epidemiological Data. New York, Oxford University Press, 2004, pp 75-92.
5. Becher H, Grau A, Steindorf K, Buggle F, Hacke W: Previous infection and other risk factors for acute cerebrovascular ischaemia: attributable risks and the characterisation of high risk groups. J Epidemiol Biostat 2000;5:277-283.
6. Taylor JMG, Yu MG: Bias and efficiency loss due to categorizing an explanatory variable. J Multivariate Anal 2002;83:248-263.
7. Ragland DR: Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology 1992;3:434-440.
8. van Belle G: Epidemiology; in Balding DJ (ed): Statistical Rules of Thumb. New York, Wiley, 2002, pp 75-102.
9. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
10. Frost L, Vukelic Andersen L, Johnsen SP, Mortensen LS: Lost life years attributable to stroke among patients with nonvalvular atrial fibrillation: a nationwide populationbased follow-up study. Neuroepidemiology 2007;29:59-65.
11. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501.